<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35022808</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>17</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1971</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Pediatric cardiology</Title><ISOAbbreviation>Pediatr Cardiol</ISOAbbreviation></Journal><ArticleTitle>Possible Association of Pulmonary Atresia with In-Utero Coxsackievirus B Exposure.</ArticleTitle><Pagination><StartPage>960</StartPage><EndPage>968</EndPage><MedlinePgn>960-968</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00246-021-02805-9</ELocationID><Abstract><AbstractText>Gestational viral infection has been associated with congenital heart disease (CHD). Few studies, however, have studied the potential role of gestational Coxsackievirus B (CVB) exposure in the pathogenesis of CHD. We prospectively enrolled women with pregnancies affected by CHD to explore possible associations with in utero CVB exposure. Serum samples were obtained from 122 women referred for fetal echocardiography between 2006 and 2018. We quantified CVB IgG and IgM levels, with titers&#x2009;&#x2265;&#x2009;15.0&#xa0;U/mL considered positive and measured neutralizing antibodies for three CVB serotypes: CVB1, CVB3, and CVB4. Using data from the national enterovirus surveillance system, we compared the annual exposure rates for each serotype in our cohort to infections reported across the United States. 98 pregnancies with no genetic defects were included. Overall, 29.6% (29/98) had positive IgG and 4.1% (4/98) of women had positive CVB IgM titers. To explore first-trimester CVB exposure, we focused exclusively on the 26 women with positive IgG and negative IgM titers. 61.5% (16/26) had neutralizing antibodies against a single serotype and 38.5% (10/26) against multiple CVB serotypes. CVB4 neutralizing antibodies were the most common (65.4%, 17/26), followed by CVB3 (53.9%, 14/26) and CVB1 (30.8%, 8/26). Among these, 30.8% of babies presented pulmonary valve anomalies: 19.2% (5/26) pulmonary atresia, and 11.5% (3/26) pulmonary stenosis. 23.1% (6/26) of babies had coronary sinusoids. CVB exposure in our cohort mirrored that of reported infections in the United States. Our results suggest a possible association between gestational CVB exposure and specific CHD, particularly pulmonary valve anomalies and coronary sinusoids.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Carvajal</LastName><ForeName>Horacio G</ForeName><Initials>HG</Initials><Identifier Source="ORCID">0000-0003-1424-8472</Identifier><AffiliationInfo><Affiliation>Section of Pediatric Cardiothoracic Surgery, Department of Surgery, Washington University in St. Louis School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharma</LastName><ForeName>Vipul</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Section of Pediatric Cardiothoracic Surgery, Department of Surgery, Washington University in St. Louis School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goessling</LastName><ForeName>Lisa S</ForeName><Initials>LS</Initials><AffiliationInfo><Affiliation>Section of Pediatric Cardiothoracic Surgery, Department of Surgery, Washington University in St. Louis School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Merritt</LastName><ForeName>Taylor C</ForeName><Initials>TC</Initials><AffiliationInfo><Affiliation>Section of Pediatric Cardiothoracic Surgery, Department of Surgery, Washington University in St. Louis School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brar</LastName><ForeName>Anoop K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Section of Pediatric Cardiothoracic Surgery, Department of Surgery, Washington University in St. Louis School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eghtesady</LastName><ForeName>Pirooz</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Section of Pediatric Cardiothoracic Surgery, Department of Surgery, Washington University in St. Louis School of Medicine, St. Louis, MO, USA. eghtesady670@wustl.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>, One Children's Place, Suite 6120, St. Louis, MO, 63110, USA. eghtesady670@wustl.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 HL098634</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01HL098634</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Pediatr Cardiol</MedlineTA><NlmUniqueID>8003849</NlmUniqueID><ISSNLinking>0172-0643</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D057134">Antibodies, Neutralizing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007075">Immunoglobulin M</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D057134" MajorTopicYN="N">Antibodies, Neutralizing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="Y">Coxsackievirus Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="N">Enterovirus B, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006330" MajorTopicYN="Y">Heart Defects, Congenital</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007075" MajorTopicYN="N">Immunoglobulin M</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018633" MajorTopicYN="Y">Pulmonary Atresia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>10</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>12</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>13</Day><Hour>6</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35022808</ArticleId><ArticleId IdType="pmc">PMC8754073</ArticleId><ArticleId IdType="doi">10.1007/s00246-021-02805-9</ArticleId><ArticleId IdType="pii">10.1007/s00246-021-02805-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Jenkins KJ, Correa A, Feinstein JA, et al. Noninherited risk factors and congenital cardiovascular defects: current knowledge&#x2014;a scientific statement from the American Heart Association Council on cardiovascular disease in the young. Circulation. 2007;115:2995&#x2013;3014. doi: 10.1161/CIRCULATIONAHA.106.183216.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.106.183216</ArticleId><ArticleId IdType="pubmed">17519397</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye Z, Wang L, Yang T, et al. Maternal viral infection and risk of fetal congenital heart diseases: a meta-analysis of observational studies. J Am Heart Assoc. 2019;8:1&#x2013;13. doi: 10.1161/JAHA.118.011264.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.118.011264</ArticleId><ArticleId IdType="pmc">PMC6512143</ArticleId><ArticleId IdType="pubmed">30995883</ArticleId></ArticleIdList></Reference><Reference><Citation>Botto LD, Erickson JD, Mulinare J, et al. Maternal fever, multivitamin use, and selected birth defects: evidence of interaction? Epidemiology. 2002;13:485&#x2013;488. doi: 10.1097/00001648-200207000-00019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001648-200207000-00019</ArticleId><ArticleId IdType="pubmed">12094106</ArticleId></ArticleIdList></Reference><Reference><Citation>Botto LD, Panichello JD, Browne ML, et al. Congenital heart defects after maternal fever. Am J Obstet Gynecol. 2014;210:359.e1&#x2013;359.e11. doi: 10.1016/j.ajog.2013.10.880.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2013.10.880</ArticleId><ArticleId IdType="pubmed">24184180</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia YQ, Zhao KN, Zhao AD, et al. Associations of maternal upper respiratory tract infection/influenza during early pregnancy with congenital heart disease in offspring: evidence from a case-control study and meta-analysis. BMC Cardiovasc Disord. 2019;19:1&#x2013;13. doi: 10.1186/s12872-019-1206-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12872-019-1206-0</ArticleId><ArticleId IdType="pmc">PMC6889668</ArticleId><ArticleId IdType="pubmed">31791237</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo L, Qu P, Zhang R, et al. Propensity score-matched analysis on the association between pregnancy infections and adverse birth outcomes in rural Northwestern China. Sci Rep. 2018 doi: 10.1038/s41598-018-23306-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-23306-5</ArticleId><ArticleId IdType="pmc">PMC5979963</ArticleId><ArticleId IdType="pubmed">29581446</ArticleId></ArticleIdList></Reference><Reference><Citation>Harvala H, Broberg E, Benschop K, et al. Recommendations for enterovirus diagnostics and characterisation within and beyond Europe. J Clin Virol. 2018;101:11&#x2013;17. doi: 10.1016/j.jcv.2018.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2018.01.008</ArticleId><ArticleId IdType="pubmed">29414181</ArticleId></ArticleIdList></Reference><Reference><Citation>Muehlenbachs A, Bhatnagar J, Zaki SR. Tissue tropism, pathology and pathogenesis of enterovirus infection. J Pathol. 2015;235:217&#x2013;228. doi: 10.1002/path.4438.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.4438</ArticleId><ArticleId IdType="pubmed">25211036</ArticleId></ArticleIdList></Reference><Reference><Citation>Wits&#xf8; E, Palacios G, Cinek O, et al. High prevalence of human enterovirus A infections in natural circulation of human enteroviruses. J Clin Microbiol. 2006;44:4095&#x2013;4100. doi: 10.1128/JCM.00653-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00653-06</ArticleId><ArticleId IdType="pmc">PMC1698346</ArticleId><ArticleId IdType="pubmed">16943351</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xe9;reaux J, Picone O, Vauloup-Fellous C, et al. L&#x2019;infection &#xe0; ent&#xe9;rovirus durant la grossesse: une cause sous-estim&#xe9;e de complications f&#x153;tale et n&#xe9;onatale ? Gynecol Obstet Fertil Senol. 2017;45:231&#x2013;237. doi: 10.1016/j.gofs.2017.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gofs.2017.02.004</ArticleId><ArticleId IdType="pubmed">28373042</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown GC, Evans TN. Serologic evidence of coxsackievirus etiology of congenital heart disease. JAMA. 1967;199:183. doi: 10.1001/jama.1967.03120030087016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.1967.03120030087016</ArticleId><ArticleId IdType="pubmed">5333944</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, Chen C, Lisewski U, et al. Cardiac deletion of the coxsackievirus-adenovirus receptor abolishes coxsackievirus B3 infection and prevents myocarditis in vivo. J Am Coll Cardiol. 2009;53:1219&#x2013;1226. doi: 10.1016/j.jacc.2008.10.064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2008.10.064</ArticleId><ArticleId IdType="pubmed">19341864</ArticleId></ArticleIdList></Reference><Reference><Citation>Hotta Y, Honda T, Naito M, Kuwano R. Developmental distribution of coxsackie virus and adenovirus receptor localized in the nervous system. Dev Brain Res. 2003;143:1&#x2013;13. doi: 10.1016/S0165-3806(03)00035-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0165-3806(03)00035-X</ArticleId><ArticleId IdType="pubmed">12763576</ArticleId></ArticleIdList></Reference><Reference><Citation>Excoffon KJDA. The coxsackievirus and adenovirus receptor: virological and biological beauty. FEBS Lett. 2020;594:1828&#x2013;1837. doi: 10.1002/1873-3468.13794.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1873-3468.13794</ArticleId><ArticleId IdType="pubmed">32298477</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma V, Perry DJ, Eghtesady P. Role of coxsackie-adenovirus receptor in cardiac development and pathogenesis of congenital heart disease. Birth Defects Res. 2021;113:535&#x2013;545. doi: 10.1002/bdr2.1860.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bdr2.1860</ArticleId><ArticleId IdType="pubmed">33369284</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma V, Goessling LS, Brar AK, et al. Coxsackievirus B3 infection early in pregnancy induces congenital heart defects through suppression of fetal cardiomyocyte proliferation. J Am Heart Assoc. 2021 doi: 10.1161/jaha.120.017995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/jaha.120.017995</ArticleId><ArticleId IdType="pmc">PMC7955305</ArticleId><ArticleId IdType="pubmed">33440998</ArticleId></ArticleIdList></Reference><Reference><Citation>Pons-Salort M, Grassly NC. Serotype-specific immunity explains the incidence of diseases caused by human enteroviruses. Science. 2018;361:800&#x2013;803. doi: 10.1126/science.aat6777.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aat6777</ArticleId><ArticleId IdType="pmc">PMC6559928</ArticleId><ArticleId IdType="pubmed">30139872</ArticleId></ArticleIdList></Reference><Reference><Citation>Villarruel GR, Langley GE, Oberste MS, Pallansch M. Nonpolio enterovirus and human parechovirus surveillance&#x2014;United States, 2006&#x2013;2008. Morb Mortal Wkly Rep. 2010;59:2006&#x2013;2008.</Citation><ArticleIdList><ArticleId IdType="pubmed">21150865</ArticleId></ArticleIdList></Reference><Reference><Citation>Abedi GR, Watson JT, Pham H, et al. Enterovirus and human parechovirus surveillance&#x2014;United States, 2009&#x2013;2013. Morb Mortal Wkly Rep. 2015;64:940&#x2013;943. doi: 10.15585/mmwr.mm6434a3.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6434a3</ArticleId><ArticleId IdType="pubmed">26334674</ArticleId></ArticleIdList></Reference><Reference><Citation>Abedi GR, Watson JT, Nix WA, et al. Enterovirus and parechovirus surveillance&#x2014;United States, 2014&#x2013;2016. Morb Mortal Wkly Rep. 2018;67:515&#x2013;518. doi: 10.15585/mmwr.mm6718a2.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6718a2</ArticleId><ArticleId IdType="pmc">PMC5944979</ArticleId><ArticleId IdType="pubmed">29746455</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xe4;kel&#xe4; O, Lapinleimu K, Kostiainen E. Timing of different virus neutralizing 19S and 7S antibodies in natural coxsackie infections of newborn babies and adults. Clin Exp Immunol. 1968;3:269&#x2013;26976.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1578887</ArticleId><ArticleId IdType="pubmed">5658457</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown GC, Karunas RS. Relationship of congenital anomalies and maternal infection with selected enteroviruses. Am J Epidemiol. 1972;95:207&#x2013;217. doi: 10.1093/oxfordjournals.aje.a121388.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.aje.a121388</ArticleId><ArticleId IdType="pubmed">5010819</ArticleId></ArticleIdList></Reference><Reference><Citation>Stene LC, Rewers M. Immunology in the clinic review series; focus on type 1 diabetes and viruses: the enterovirus link to type 1 diabetes: critical review of human studies. Clin Exp Immunol. 2012;168:12&#x2013;23. doi: 10.1111/j.1365-2249.2011.04555.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2249.2011.04555.x</ArticleId><ArticleId IdType="pmc">PMC3390488</ArticleId><ArticleId IdType="pubmed">22385232</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregg NM. Congenital cataract following german measles in the mother. Epidemiol Infect. 1991;107:iii&#x2013;xiv. doi: 10.5694/j.1326-5377.1941.tb50952.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.5694/j.1326-5377.1941.tb50952.x</ArticleId><ArticleId IdType="pmc">PMC2272051</ArticleId><ArticleId IdType="pubmed">1879476</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueller M. Rubella vaccine is licensed. Science. 1969;165:48. doi: 10.1126/science.165.3888.48.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.165.3888.48</ArticleId><ArticleId IdType="pubmed">17840681</ArticleId></ArticleIdList></Reference><Reference><Citation>Papania MJ, Wallace GS, Rota PA, et al. Elimination of endemic measles, rubella, and congenital rubella syndrome from the Western hemisphere: the US experience. JAMA Pediatr. 2014;168:148&#x2013;155. doi: 10.1001/jamapediatrics.2013.4342.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2013.4342</ArticleId><ArticleId IdType="pubmed">24311021</ArticleId></ArticleIdList></Reference><Reference><Citation>Maulik D, Nanda NC, Maulik D, Vilchez G. A brief history of fetal echocardiography and its impact on the management of congenital heart disease. Echocardiography. 2017;34:1760&#x2013;1767. doi: 10.1111/echo.13713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/echo.13713</ArticleId><ArticleId IdType="pubmed">29287130</ArticleId></ArticleIdList></Reference><Reference><Citation>Gramiak R, Nanda NC. Echocardiographic detection of the pulmonary valve. Radiology. 1972;102:153&#x2013;157. doi: 10.1148/102.1.153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/102.1.153</ArticleId><ArticleId IdType="pubmed">4550314</ArticleId></ArticleIdList></Reference><Reference><Citation>Foker JE, Setty SP, Berry J, et al. Treatment of right ventricle to coronary artery connections in infants with pulmonary atresia and intact ventricular septum. J Thorac Cardiovasc Surg. 2008;136:749&#x2013;756. doi: 10.1016/j.jtcvs.2008.03.067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2008.03.067</ArticleId><ArticleId IdType="pubmed">18805281</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakamy R, S&#xe9;gu&#xe9;la P-E, Valdeolmillos E, et al. Pulmonary atresia with ventriculocoronary arterial connections&#xa0;and a large conoventricular&#xa0;septal defect. JACC. 2019;1:545&#x2013;548. doi: 10.1016/j.jaccas.2019.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaccas.2019.09.008</ArticleId><ArticleId IdType="pmc">PMC8288796</ArticleId><ArticleId IdType="pubmed">34316875</ArticleId></ArticleIdList></Reference><Reference><Citation>Gittenberger-de Groot AC, Tennstedt C, Chaoui R, et al. Ventriculo coronary arterial communications (VCAC) and myocardial sinusoids in hearts with pulmonary atresia with intact ventricular septum: two different diseases. Prog Pediatr Cardiol. 2001;13:157&#x2013;164. doi: 10.1016/S1058-9813(01)00102-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1058-9813(01)00102-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Gittenberger-de Groot AC, Jongbloed MRM, Wisse LJ, Poelmann RE. Pulmonary atresia with intact ventricular septum: second heart field derived myocardial and epicardial developmental clues. Prog Pediatr Cardiol. 2010;29:3&#x2013;9. doi: 10.1016/j.ppedcard.2010.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ppedcard.2010.02.009</ArticleId></ArticleIdList></Reference><Reference><Citation>Lougheed J, Sinclair BG, Fung Kee Fung K, et al. Acquired right ventricular outflow tract obstruction in the recipient twin in twin-twin transfusion syndrome. J Am Coll Cardiol. 2001;38:1533&#x2013;1538. doi: 10.1016/S0735-1097(01)01549-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0735-1097(01)01549-2</ArticleId><ArticleId IdType="pubmed">11691536</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelfelder E, Tan X, Cnota J, et al. Prevalence, spectrum, and outcome of right ventricular outflow tract abnormalities in twin-twin transfusion syndrome: a large, single-center experience. Congenit Heart Dis. 2015;10:209&#x2013;218. doi: 10.1111/chd.12215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/chd.12215</ArticleId><ArticleId IdType="pubmed">25156087</ArticleId></ArticleIdList></Reference><Reference><Citation>Oster ME, Riehle-Colarusso T, Correa A. An update on cardiovascular malformations in congenital rubella syndrome. Birth Defects Res Part A. 2009 doi: 10.1002/bdra.20621.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bdra.20621</ArticleId><ArticleId IdType="pubmed">19697432</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekure EN, Kalu N, Sokunbi OJ, et al. Clinical epidemiology of congenital heart disease in Nigerian children, 2012&#x2013;2017. Birth Defects Res. 2018;110:1233&#x2013;1240. doi: 10.1002/bdr2.1361.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bdr2.1361</ArticleId><ArticleId IdType="pubmed">30230273</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson BT. The pathogenesis of congenital cardiovascular anomalies. N Engl J Med. 1968;279:80&#x2013;89. doi: 10.1056/NEJM196807112790206.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM196807112790206</ArticleId><ArticleId IdType="pubmed">4872379</ArticleId></ArticleIdList></Reference><Reference><Citation>Naeye RL, Blanc W. Pathogenesis of congenital rubella. JAMA. 1965;194:1277&#x2013;1283. doi: 10.1001/jama.1965.03090250011002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.1965.03090250011002</ArticleId><ArticleId IdType="pubmed">5898080</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazar M, Perelygina L, Martines R, et al. Immunolocalization and distribution of rubella antigen in fatal congenital rubella syndrome. EBioMedicine. 2016;3:86&#x2013;92. doi: 10.1016/j.ebiom.2015.11.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2015.11.050</ArticleId><ArticleId IdType="pmc">PMC4739417</ArticleId><ArticleId IdType="pubmed">26870820</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorner AA, Wegmann F, Butz S, et al. Coxsackievirus-adenovirus receptor (CAR) is essential for early embryonic cardiac development. J Cell Sci. 2005;118:3509&#x2013;3521. doi: 10.1242/jcs.02476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.02476</ArticleId><ArticleId IdType="pubmed">16079292</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SEF, Anderson DE, Wei WE, et al. Connecting clusters of COVID-19: an epidemiological and serological investigation. Lancet Infect Dis. 2020;20:809&#x2013;815. doi: 10.1016/S1473-3099(20)30273-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30273-5</ArticleId><ArticleId IdType="pmc">PMC7173813</ArticleId><ArticleId IdType="pubmed">32330439</ArticleId></ArticleIdList></Reference><Reference><Citation>Alford CA, Schaefer J, Blankenship WJ, et al. A correlative immunologic, microbiologic and clinical approach to the diagnosis of acute and chronic infections in newborn infants. N Engl J Med. 1967;277:437&#x2013;449. doi: 10.1056/NEJM196708312770901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM196708312770901</ArticleId><ArticleId IdType="pubmed">4166354</ArticleId></ArticleIdList></Reference><Reference><Citation>Weller TH, Alford CA, Neva FA. Retrospective diagnosis by serologic means of congenitally acquired rubella infections. N Engl J Med. 1964;270:1039&#x2013;1041. doi: 10.1056/NEJM196405142702004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM196405142702004</ArticleId><ArticleId IdType="pubmed">14122801</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuramitsu M, Kuroiwa C, Yoshida H, et al. Non-polio enterovirus isolation among families in Ulaanbaatar and Tov province, Mongolia: prevalence, intrafamilial spread, and risk factors for infection. Epidemiol Infect. 2005;133:1131&#x2013;1142. doi: 10.1017/S0950268805004139.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268805004139</ArticleId><ArticleId IdType="pmc">PMC2870349</ArticleId><ArticleId IdType="pubmed">16274512</ArticleId></ArticleIdList></Reference><Reference><Citation>Wikswo ME, Khetsuriani N, Fowlkes AL, et al. Increased activity of coxsackievirus B1 strains associated with severe disease among young infants in the United States, 2007&#x2013;2008. Clin Infect Dis. 2009;49:2007&#x2013;2008. doi: 10.1086/605090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/605090</ArticleId><ArticleId IdType="pubmed">19622041</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention (CDC) Increased detections and severe neonatal disease associated with coxsackievirus B1 infection&#x2013;United States, 2007. Morb Mortal Wkly Rep. 2008;57:553&#x2013;556.</Citation><ArticleIdList><ArticleId IdType="pubmed">18496504</ArticleId></ArticleIdList></Reference><Reference><Citation>Isaacs SR, Kim KW, Cheng JX, et al. Amplification and next generation sequencing of near full-length human enteroviruses for identification and characterisation from clinical samples. Sci Rep. 2018;8:1&#x2013;9. doi: 10.1038/s41598-018-30322-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-30322-y</ArticleId><ArticleId IdType="pmc">PMC6082906</ArticleId><ArticleId IdType="pubmed">30089864</ArticleId></ArticleIdList></Reference><Reference><Citation>Dommergues M, Petitjean J, Aubry MC, et al. Fetal enteroviral infection with cerebral ventriculomegaly and cardiomyopathy. Fetal Diagn Ther. 1994;9:77&#x2013;78. doi: 10.1159/000263911.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000263911</ArticleId><ArticleId IdType="pubmed">8185842</ArticleId></ArticleIdList></Reference><Reference><Citation>Euscher E, Davis J, Holzman I, Nuovo GJ. Coxsackie virus infection of the placenta associated with neurodevelopmental delays in the newborn. Obstet Gynecol. 2001;98:1019&#x2013;1026. doi: 10.1016/S0029-7844(01)01625-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0029-7844(01)01625-8</ArticleId><ArticleId IdType="pubmed">11755547</ArticleId></ArticleIdList></Reference><Reference><Citation>Gauntt CJ, Gudvangen RJ, Brans YW, Marlin AE. Coxsackievirus group B antibodies in the ventricular fluid of infants with severe anatomic defects in the central nervous system. Pediatrics. 1985;76:64&#x2013;68. doi: 10.1542/peds.76.1.64.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.76.1.64</ArticleId><ArticleId IdType="pubmed">2989763</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>